Latest News

New SGLT2 inhibitor drugs developed despite growing list of side effects

The SGLT2 inhibitor class of type 2 diabetes medications is expected to continue to grow in the coming months with new treatments on the verge of Food and Drug Administration (FDA) approval and positive cardiovascular outcomes data. But the drugs remain saddled with a growing list of side effects. The FDA is currently reviewing a new SGLT2 inhibitor from Pfizer and Merck called ertugliflozin, an oral therapy that lowers blood glucose levels by allowing excess glucose to be secreted through the urine. Merck is also poised to obtain clearance for other ertugliflozin combination drugs, such as one that includes the ... Read More

Natural remedies for hair loss can’t help Taxotere users

Everyone loses some hair, with the loss of 74 to 100 old hairs per day being normal as hairs reach the end of their four- to six-year lifespan. However, some people experience excessive hair loss. This can be caused by autoimmune disease alopecia; damaging hair treatments and styles; side effects of medications such as chemotherapy; as well as changes such as pregnancy, stress, and weight loss. Health issues such as some vitamin deficiencies, thyroid disease, liver malfunction, and even high blood pressure can also have an effect on your hair, causing unwanted excessive loss. For those who might be dealing ... Read More

FDA warns makers, distributors of ‘chocolate snuff’

The Food and Drug Administration (FDA) is warning marketers and distributors of “snortable” chocolate powder, calling the products misbranded, unapproved new drugs. The warning letters targeted Legal Lean Syrup and Coco Loko, the safety labels of which the agency says “demonstrate that the products are intended to be used as alternatives to illicit street drugs.” The way the drugs are labeled and marketed raises safety concerns, the agency said, because they encourage drug abuse in individuals, including minors. “As a physician and a parent, I’m deeply troubled by the unlawful marketing of these potentially dangerous products, especially since they are ... Read More

Whistleblower Fired For Contesting Asbestos Violations Awarded $173,000

Federal authorities ordered a New York demolition and construction company to pay a whistleblower it allegedly fired for reporting asbestos safety concerns more than $173,000. The Occupational Safety and Health Administration (OSHA) said that it investigated Champagne Demolition LLC, an Albany-based company, and its owner Joseph Champagne in response to a worker’s complaint about improper asbestos removal practices at a New York school site. Although OSHA didn’t provide details about the alleged asbestos violations, companies that fail to follow specific procedures for proper removal not only endanger their workers but potentially expose others as well. On June 10, 2010, the ... Read More

Woman’s IVC filter punctured aortic wall

Susie Allen was only 49 years old when she was implanted with a Cook Celect IVC filter, a tiny, cage-like device placed inside the inferior vena cava (IVC) – a large vein that delivers deoxygenated blood from the lower extremities – designed to catch blood clots before they reach the heart. But something went horribly wrong. In January 2012, nearly four years after receiving the IVC filter, doctors discovered that the device had fractured inside her body. In July 2013, doctors discovered that one of the fractured legs of the filter had perforated her aortic wall – the main artery ... Read More

Two Florida hospitals sue opioid makers for fueling abuse

Two Florida hospitals filed lawsuits against a group of pharmacies, drug makers, and drug distributors, accusing them of bolstering the nation’s opioid epidemic by filling suspicious prescriptions for the highly addictive painkillers and downplaying the risks associated with the drugs. Baptist Hospital Inc., and Jay Hospital Inc., filed suit against distributors McKesson Corp., Cardinal Health Inc., and AmerisourceBergen; pharmacies CVS Health, Walgreens Boots Alliance Inc., and Wal-Mart Stores Inc.; and manufacturers Purdue Pharma, Teva Pharmaceutical Industries and its unit Cephalon Inc., Endo Health Solutions Inc., Johnson & Johnson and its subsidiary Janssen Pharmaceuticals; and Actavis Inc., and its units Allergan ... Read More

NZ residents push for ban of hernia mesh

New Zealand’s medical authority Medsafe has banned the use of surgical mesh for gynecological procedures like pelvic organ prolapse and stress urinary incontinence, effective Jan. 4, 2018. Now some residents are calling for an even wider ban of the products, arguing that similar complications can occur when the mesh is used for hernia repair and it should be banned outright. Karyn Freer was implanted with a hernia mesh but was in so much pain that she underwent surgery to remove the mesh. She died in June 2014, while still recovering from hernia mesh removal surgery. Mesh for hernia repair as ... Read More

NTSB Investigating Deadly Charter Airplane Crash Near San Diego

Federal investigators are looking for answers in an airplane crash that destroyed a San Diego-area home Saturday evening, killing two passengers and a dog on the ground. According to NBC 7 San Diego, a single-engine Beechcraft charter plane operated by Altitude Aviation of Hermosa Beach crashed into the back of a Clairemont, California home around 4:30 p.m. Dec. 9. The explosion the airplane crash created and ensuing fire destroyed the home and everything inside. Four people including the pilot were aboard the charter plane. The airplane crash killed two of the passengers. The pilot and another passenger survived with injuries. ... Read More

PA Xarelto trials focus on US bleeding risks

The first Xarelto side effects bellwether trial in a pool of about 1,500 pending in Philadelphia County Court of Common Pleas resulted in a $28 million verdict in favor of Lynn Hartman, who sued Xarelto makers Johnson & Johnson’s Janssen Pharmaceuticals and Bayer alleging Xarelto caused her to bleed internally. The next trials in Philadelphia are scheduled for March, April, May and June. Apart from the cases pending in the Philadelphia mass tort program, another 18,000 lawsuits consolidated in a multidistrict litigation (MDL) in the Eastern District of Louisiana are pending. Three have been tried and fell in favor of ... Read More

CSPI calls for ban of supplements that claim to treat opioid addiction

The Center for Science in the Public Interest (CSPI) is calling on the Food and Drug Administration (FDA) to ban the sale of dietary supplements that claim to treat opioid addiction, and for the Federal Trade Commission (FTC) to prohibit supplement companies from making false claims on websites and ads. “These supplement companies are giving false hope to people who are desperate to get better,” says Bachaar Arnaout, an addiction psychiatrist and assistant professor at the Yale School of Medicine. “The danger people face by being misled is that they will be resorting to ineffective products, instead of evidence-based treatments, ... Read More